BioCorRx (BICX) Research & Development (2017 - 2026)
BioCorRx (BICX) posted Research & Development of $352,333 for Q1 2026, up 117.6% from $161,919 a year earlier and up 15.3% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Research & Development at BioCorRx was $1.96 million, up 36.9% year-over-year; for FY2025, it came in at $1.77 million, up 19.3% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- In prior years, BioCorRx's Research & Development was $1.48 million in FY2024 (+66.4%), $891,063 in FY2023 (-38.9%), $1.46 million in FY2022 (-9.1%) and $1.61 million in FY2021 (-62.4%).
- Quarterly Research & Development has run from a low of $123,262 in Q2 2021 to a high of $1 million in Q3 2025 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last three quarters, with growth averaging 59.6% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2022, with growth of 210.7%; the weakest was Q2 2021, with a decline of 90.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $305,516 (Q4 2025), $1 million (Q3 2025) and $296,860 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 352,333.00 |
| Dec 31, 2025 | 305,516.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 296,860.00 |
| Mar 31, 2025 | 161,919.00 |
| Dec 31, 2024 | 272,543.00 |
| Sep 30, 2024 | 460,138.00 |
| Jun 30, 2024 | 536,362.00 |
| Mar 31, 2024 | 213,834.00 |
| Dec 31, 2023 | 128,295.00 |
| Sep 30, 2023 | 286,962.00 |
| Jun 30, 2023 | 238,419.00 |
| Mar 31, 2023 | 237,387.00 |
| Dec 31, 2022 | 536,104.00 |
| Sep 30, 2022 | 342,553.00 |
| Jun 30, 2022 | 382,952.00 |
| Mar 31, 2022 | 197,849.00 |
| Dec 31, 2021 | 234,423.00 |
| Sep 30, 2021 | 589,985.00 |
| Jun 30, 2021 | 123,262.00 |
API Access
BioCorRx Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();